

LONDON, Aug 31 (Reuters) - The following FTSE 100 companies will go ex-dividend on Thursday, after which investors will no longer qualify for the late...


(ShareCast News) - The chief executive of pharmaceuticals giant Shire has said he will cut costs by £1bn if his new £19bn bid to acquire Baxalta is su...


(Adds Ariad's name as acquisition target; updates shares) Aug 28 (Reuters) - Drugmaker Baxalta Inc is in talks to buy Ariad Pharmaceuticals Inc to boo...


Aug 28 (Reuters) - Drugmaker Baxalta Inc is working with bankers to buy a U.S.-based hematology and oncology specialist valued at about $2 billion, Bl...




(ShareCast News) - By mid afternoon on Friday, the FTSE 100 was almost exactly flat on the day, meaning despite all the drama of China's 'Black Monday...



